JMI LABS IS NOW PART OF LEARN MORE

Oritavancin microbiologic features and activity results from the surveillance program in the United States. by Mendes RE, Farrell DJ, Sader HS and Jones RN published in Clin. Infect. Dis. 2012; 54 (Suppl 3): S203-S213

View publication